Genvor Acquires Founder’s Synthetic Peptide IP and Research Data
Genvor entered into an agreement with founder and Chief Scientific Officer Jesse Jaynes to acquire rights to synthetic and designed peptide sequences, including approximately 9,000 antimicrobial peptides, plus related research data and design materials.
Genvor entered into an intellectual property assignment agreement with founder and Chief Scientific Officer Jesse Jaynes to acquire rights to synthetic and designed peptide sequences, including approximately 9,000 antimicrobial peptides, and associated research data and design materials. The assign…